- Report
- August 2022
Global
From €749EUR$790USD£632GBP
- Report
- August 2022
Global
From €749EUR$790USD£632GBP
- Drug Pipelines
- November 2020
- 3809 Pages
Global
From €2369EUR$2,500USD£1,999GBP
- Drug Pipelines
- April 2023
- 34 Pages
Global
From €9471EUR$9,995USD£7,993GBP
From €1421EUR$1,500USD£1,200GBP
- Report
- April 2024
- 80 Pages
United Kingdom
From €1421EUR$1,500USD£1,200GBP
- Report
- April 2024
- 80 Pages
Vietnam
From €1421EUR$1,500USD£1,200GBP
- Report
- April 2024
- 80 Pages
Argentina
From €1421EUR$1,500USD£1,200GBP
- Report
- April 2024
- 80 Pages
Brazil
From €1421EUR$1,500USD£1,200GBP
- Report
- April 2024
- 80 Pages
China
From €1421EUR$1,500USD£1,200GBP
- Report
- April 2024
- 80 Pages
France
From €1421EUR$1,500USD£1,200GBP
- Report
- April 2024
- 80 Pages
Germany
From €1421EUR$1,500USD£1,200GBP
- Report
- April 2024
- 80 Pages
India
From €1421EUR$1,500USD£1,200GBP
- Report
- April 2024
- 80 Pages
Ireland
From €1421EUR$1,500USD£1,200GBP
- Report
- April 2024
- 80 Pages
Japan
From €1421EUR$1,500USD£1,200GBP
- Report
- April 2024
- 80 Pages
Poland
From €1421EUR$1,500USD£1,200GBP
- Report
- April 2024
- 80 Pages
Russia
From €1421EUR$1,500USD£1,200GBP
- Report
- April 2024
- 80 Pages
Saudi Arabia
From €1421EUR$1,500USD£1,200GBP
- Report
- April 2024
- 80 Pages
South Korea
From €1421EUR$1,500USD£1,200GBP
- Report
- February 2022
- 40 Pages
India
From €1421EUR$1,500USD£1,200GBP

The Skin Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat skin cancer. These drugs are used to treat a variety of skin cancer types, including melanoma, basal cell carcinoma, and squamous cell carcinoma. The drugs are typically administered orally, intravenously, or topically.
The market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Novartis, Pfizer, and Roche. These companies are constantly researching and developing new treatments to improve the efficacy of existing treatments and to develop new treatments for skin cancer.
In addition to the major players, there are also many smaller companies that are developing treatments for skin cancer. These companies are often focused on developing treatments for rarer forms of skin cancer, such as Merkel cell carcinoma. Examples of these companies include Aduro Biotech, Arcutis Biotherapeutics, and OncoSec Medical. Show Less Read more